Canagliflozin Alternatives in Nevada
Compare generic and therapeutic alternatives to Canagliflozin (canagliflozin) available at Nevada pharmacies. Save up to 48% on your prescription — no insurance required.
Top Alternatives in Nevada
Metformin
therapeutic
First-line T2D medication — dramatically cheaper
Avg cash price: $8/mo
Dapagliflozin (Farxiga)
therapeutic
Competing SGLT2 inhibitor with similar profile
Avg cash price: $530/mo
Empagliflozin (Jardiance)
therapeutic
SGLT2 inhibitor with strong cardiovascular outcomes data
Avg cash price: $560/mo
Nevada Prescription Assistance Programs
Nevada Medicaid Rx (Nevada Check Up/Nevada Medicaid)
Prescription drug coverage for Nevada Medicaid and Nevada Check Up (CHIP) beneficiaries.
Eligibility: Low-income Nevada adults up to 138% FPL, children up to 200% FPL through Check Up, and people with disabilities.
NevadaRx (Senior Prescription Assistance)
State-supported program helping seniors navigate Medicare Part D plan selection, Extra Help enrollment, and pharmaceutical manufacturer assistance.
Eligibility: Nevada residents aged 60+ or with disabilities seeking prescription cost assistance. Contact the Nevada Aging and Disability Services Division at 1-800-992-0900.
Frequently Asked Questions
Is there a generic for canagliflozin (Invokana)?
Not yet as of 2025. Canagliflozin is still under brand exclusivity as Invokana. All SGLT2 inhibitors remain brand-only at similar high prices.
How does canagliflozin compare to other SGLT2 inhibitors?
Canagliflozin, dapagliflozin, and empagliflozin have similar glucose-lowering effects. Differences emerge in cardiovascular and renal outcomes data — your cardiologist or endocrinologist guides the choice.
What is the main risk specific to canagliflozin?
Canagliflozin carries an FDA warning about increased risk of lower-limb amputations, particularly in patients with peripheral vascular disease. Discuss your individual risk with your doctor.
Can Script Unlock help with canagliflozin costs?
While there is no generic, Script Unlock pharmacies sometimes offer lower cash-pay brand pricing. It is worth posting your script to compare bids.
Is metformin a good alternative to canagliflozin for T2D?
Metformin is first-line T2D therapy at under $10/month. SGLT2 inhibitors like canagliflozin are added for patients who need additional cardiovascular or renal benefits beyond glucose lowering.